24 Grants
2021
Chemical Biology Studies of the Dynamics and Inhibition of Peptidoglycan Biosynthesis
Vannieuwenhze, Michael S
National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS) (ID: 5R35GM136365-02), $375,579USD, 2020-04-01 -- 2025-02-28
2020
Chemical Biology Studies of the Dynamics and Inhibition of Peptidoglycan Biosynthesis
Vannieuwenhze, Michael S
National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS) (ID: 1R35GM136365-01), $375,579USD, 2020-04-01 -- 2025-02-28
2018
Dynamics of bacterial peptidoglycan synthesis
Brun, Yves V⋅Vannieuwenhze, Michael S and Winkler, Malcolm E
National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS) (ID: 5R01GM113172-04), $766,702USD, 02/05/2015 -- 11/30/2018
2017
Dynamics of bacterial peptidoglycan synthesis
Brun, Yves V⋅Vannieuwenhze, Michael S and Winkler, Malcolm E
National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS) (ID: 5R01GM113172-03), $766,702USD, 02/05/2015 -- 11/30/2018
 
Novel Inhibitors of Peptidoglycan Biosynthesis Targeting Gram-positive Pathogens
Vannieuwenhze, Michael S
National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS) (ID: 5R01GM111537-04), $347,101USD, 09/01/2014 -- 08/31/2018
2016
Dynamics of bacterial peptidoglycan synthesis
Brun, Yves V⋅Vannieuwenhze, Michael S and Winkler, Malcolm E
National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS) (ID: 5R01GM113172-02), $766,702USD, 02/05/2015 -- 11/30/2018
 
Dynamics of bacterial peptidoglycan synthesis
Brun, Yves V⋅Vannieuwenhze, Michael S and Winkler, Malcolm E
National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS) (ID: 3R01GM113172-02S1), $135,193USD, 02/05/2015 -- 11/30/2018
 
Novel Inhibitors of Peptidoglycan Biosynthesis Targeting Gram-positive Pathogens
Vannieuwenhze, Michael S
National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS) (ID: 5R01GM111537-03), $347,101USD, 09/01/2014 -- 08/31/2018
2015
Dynamics of bacterial peptidoglycan synthesis
Brun, Yves V⋅Vannieuwenhze, Michael S and Winkler, Malcolm E
National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS) (ID: 1R01GM113172-01), $841,823USD, 02/05/2015 -- 11/30/2018
 
Novel Inhibitors of Peptidoglycan Biosynthesis Targeting Gram-positive Pathogens
Vannieuwenhze, Michael S
National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS) (ID: 5R01GM111537-02), $347,101USD, 09/01/2014 -- 08/31/2018
2014
Novel Inhibitors of Peptidoglycan Biosynthesis Targeting Gram-positive Pathogens
Vannieuwenhze, Michael S
National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS) (ID: 1R01GM111537-01), $347,101USD, 09/01/2014 -- 08/31/2018
2012
Core F(B): Synthesis Design
Vannieuwenhze, Michael S
National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS) (ID: 5U54GM069338-10), $460,348USD, 08/01/2012 -- 07/31/2014
2011
Core F(B): Synthesis Design
Vannieuwenhze, Michael S
National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS) (ID: 5U54GM069338-09), $451,816USD, 08/01/2011 -- 07/31/2012
2010
Core F(B): Synthesis Design
Vannieuwenhze, Michael S
National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS) (ID: 5U54GM069338-08), $465,052USD, 08/01/2010 -- 07/31/2011
2009
Core F(B): Synthesis Design
Vannieuwenhze, Michael S
National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS) (ID: 5U54GM069338-07), $468,690USD, 08/01/2009 -- 07/31/2010
 
Synthesis and Mechanistic Studies of Peptide Antibiotics
Vannieuwenhze, Michael S
National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) (ID: 5R01AI059327-06), $303,464USD, 12/01/2004 -- 11/30/2010
2008
Core F(B): Synthesis Design
Vannieuwenhze, Michael S
National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS) (ID: 2U54GM069338-06-9011), $480,884USD, 09/15/2008 -- 07/31/2013
 
Synthesis and Mechanistic Studies of Peptide Antibiotics
Vannieuwenhze, Michael S
National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) (ID: 5R01AI059327-05), $304,603USD, 12/01/2004 -- 11/30/2009
2007
Synthesis and Mechanistic Studies of Peptide Antibiotics
Vannieuwenhze, Michael S
National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) (ID: 7R01AI059327-04), $202,618USD, 12/01/2004 -- 11/30/2009
 
Synthesis and Mechanistic Studies of Peptide Antibiotics
Vannieuwenhze, Michael S
National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) (ID: 5R01AI059327-03), $119,703USD, 12/01/2004 -- 08/31/2007
2006
Synthesis and Mechanistic Studies of Peptide Antibiotics
Vannieuwenhze, Michael S
National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) (ID: 5R01AI059327-02), $342,786USD, 12/01/2004 -- 11/30/2009
2005
Synthesis and Mechanistic Studies of Peptide Antibiotics
Vannieuwenhze, Michael S
National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) (ID: 1R01AI059327-01A1), $234,654USD, 12/01/2004 -- 11/30/2009
2004
Synthesis and Mechanistic Studies of Peptide Antibiotics
Vannieuwenhze, Michael S
National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) (ID: 1R21AI059327-01), $352,305USD, 04/01/2004 -- 11/30/2004
1992
EPOXIDATIONS WITH CHIRALLY MODIFIED RU(V)-OXO COMPLEXES
Vannieuwenhze, Michael S
National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS) (ID: 1F32GM015299-01), 01/31/1993